10.48
-1.78%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Autek China
Its shares trade on Shenzhen under the ticker 300595.SZ. It has been listed since 17 January 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.85bn and net income of CN¥479.5m. At that date it held total assets of CN¥6.30bn and shareholders' equity of CN¥4.91bn.
Ovctek China, Inc. engages in the operation of eye vision technology. The company is headquartered in Hefei, Anhui. The company went IPO on 2017-01-17. The firm's main business is non-surgical vision correction. The firm's main products include orthokeratology, general contact lens and care products. Its core product is Dream David orthokeratology. In addition, The Company is also engaged in general glass frame sales business. The firm mainly operates its business in the domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 17 Jan 2017
- Employees
- 2,902
- Website
- orthok.cn ↗
Leadership
Pay as last reported
- Mr. Yuequn TaoChairman of the Board, General Manager, since 2013CN¥1.3m
- Mr. Lizhi WeiChief Financial Officer, Director, since 2019CN¥560,400
- Ms. Xianmei ShiChief Operating Officer, Deputy General Manager, Secretary of the Board, Director, since 2019CN¥748,500
- Ms. Zhiying FuDeputy General Manager, Chief R&D Officer, Director, since 2018CN¥766,800
- Mr. Guoxin DongDeputy General Manager, Director of Professional Affairs Management CenterCN¥786,900
- Mr. Yongzhan XiaoDeputy General ManagerCN¥877,600
- Mr. Zhe ZhuDeputy General Manager, Director of Anhui Business CenterCN¥670,400
- Ms. Yihua ChengDeputy Director of Anhui Business Center, Director, since 2013CN¥302,900
- Mr. Yongjian SunDeputy Chief Operating OfficerCN¥392,400
- Mr. Chun WangChief Production OfficerCN¥401,900
- Mr. Tongge HuangDirector
- Mr. Minsong TangIndependent DirectorCN¥69,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 35
- Environment
- 41
- Social
- 16
- Governance
- 48
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Ovctek China employs 2,902 full-time employees in Hefei, Anhui.
- Dream David orthokeratology is the core product for non-surgical vision correction.
- Ovctek China operates primarily in the domestic market within the Health Care sector.
Weaknesses
- Ovctek China's business is limited to the domestic market in China.
- The company's main products are orthokeratology and contact lenses, with limited diversification.
- Ovctek China's IPO was on 17 January 2017, indicating a relatively recent market entry.
Opportunities
- Ovctek China can expand its product line to include more vision correction solutions.
- The domestic market in China offers significant growth potential for Health Care products.
- Ovctek China could leverage its core product Dream David for international market entry.
Threats
- Ovctek China faces competition from other domestic vision correction companies in China.
- The Health Care sector in China is subject to regulatory changes that could impact operations.
- Ovctek China's reliance on the domestic market makes it vulnerable to local economic fluctuations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.